We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $999B
1-Year Est. Return 46.22%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+20.73%
1 Year Est. Return
+46.22%
3 Year Est. Return
+150.45%
5 Year Est. Return
+185.95%
10 Year Est. Return
+1,389.53%
AUM
$498B
AUM Growth
+$25.7B
Cap. Flow
-$8.9B
Cap. Flow %
-1.79%
Top 10 Hldgs %
16.86%
Holding
2,648
New
135
Increased
1,180
Reduced
817
Closed
125

Sector Composition

Rank Sector Weight
1 Healthcare 18.83%
2 Consumer Discretionary 15.39%
3 Financials 14.97%
4 Technology 13.81%
5 Communication Services 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PWR icon
1326
Quanta Services
PWR
$104B
$9.25M ﹤0.01%
330,370
-1,200
-0.4% -$30.6K
HZNP
1327
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$9.23M ﹤0.01%
509,020
+16,535
+3% +$323K
CRVL icon
1328
CorVel
CRVL
$3.3B
$9.19M ﹤0.01%
717,558
+30,000
+4% +$416K
FTR
1329
DELISTED
Frontier Communications Corp.
FTR
$9.19M ﹤0.01%
147,203
+3,416
+2% +$243K
DO
1330
DELISTED
Diamond Offshore Drilling
DO
$9.13M ﹤0.01%
518,330
-120,580
-19% -$2.42M
NERV icon
1331
Minerva Neurosciences
NERV
$215M
$9.04M ﹤0.01%
+80,056
New +$7.77M
INDA icon
1332
iShares MSCI India ETF
INDA
$6.55B
$9.03M ﹤0.01%
306,900
TGNA
1333
DELISTED
TEGNA Inc
TGNA
$9M ﹤0.01%
643,239
-4,625
-0.7% -$65K
RCKT icon
1334
Rocket Pharmaceuticals
RCKT
$363M
$8.9M ﹤0.01%
234,770
+52,662
+29% +$1.66M
ECHO
1335
EchoStar
ECHO
$26.5B
$8.82M ﹤0.01%
248,296
+8,256
+3% +$262K
NAVI icon
1336
Navient
NAVI
$837M
$8.65M ﹤0.01%
597,563
-93,410
-14% -$1.3M
ITCI
1337
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$8.59M ﹤0.01%
563,702
+554,095
+5,768% +$22.4M
PBCT
1338
DELISTED
People's United Financial Inc
PBCT
$8.53M ﹤0.01%
539,427
+200
+0% +$3.11K
CRAY
1339
DELISTED
Cray, Inc.
CRAY
$8.53M ﹤0.01%
362,367
-1,267,480
-78% -$32.3M
HAPN
1340
Happen Inc
HAPN
$2.27B
$8.51M ﹤0.01%
275,248
-81,041
-23% -$2.1M
TRMB icon
1341
Trimble
TRMB
$13.3B
$8.45M ﹤0.01%
295,931
-1,599,810
-84% -$42.8M
DISH
1342
DELISTED
DISH Network Corp.
DISH
$8.43M ﹤0.01%
153,923
+11,670
+8% +$604K
ANSS
1343
DELISTED
Ansys
ANSS
$8.43M ﹤0.01%
91,007
+3,702
+4% +$345K
ESL
1344
DELISTED
Esterline Technologies
ESL
$8.42M ﹤0.01%
110,770
+5,400
+5% +$379K
EGO icon
1345
Eldorado Gold
EGO
$10.3B
$8.4M ﹤0.01%
427,333
-229,169
-35% -$4.73M
GRPN icon
1346
Groupon
GRPN
$875M
$8.21M ﹤0.01%
79,663
+27,769
+54% +$2.71M
CLB icon
1347
Core Laboratories
CLB
$582M
$8.18M ﹤0.01%
72,800
+10,000
+16% +$1.15M
CPA icon
1348
Copa Holdings
CPA
$6.14B
$8.06M ﹤0.01%
91,673
-3,595
-4% -$273K
SNMX
1349
DELISTED
Senomyx, Inc.
SNMX
$8.03M ﹤0.01%
1,885,055
-77,200
-4% -$280K
KS
1350
DELISTED
KapStone Paper and Pack Corp.
KS
$7.97M ﹤0.01%
421,220
-3,300
-0.8% -$53K

Similar funds

T. Rowe Price Associates's Q3 2016 Portfolio in Review

As of Q3 2016, T. Rowe Price Associates held 2,648 positions worth $498B, up 5.4% from $472B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

T. Rowe Price Associates's Q3 2016 filing shows 135 new, 1,180 increased, 817 reduced and 125 closed positions. Its largest new stake was Fortive: 55,770,886 shares worth $1.79B. The largest sale was TotalEnergies, an estimated $8.15B.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q3 2016 buy was Fortive: 55,770,886 shares worth $1.79B.
  • T. Rowe Price Associates added most to PayPal in Q3 2016, an estimated $1.64B increase.
  • T. Rowe Price Associates's biggest Q3 2016 reduction was TotalEnergies, cutting an estimated $8.15B.
  • T. Rowe Price Associates fully exited TYCO INTL PLC COM SHS (IRL) in Q3 2016, selling an estimated $1.77B.
  • T. Rowe Price Associates's ten largest holdings make up 17% of its $498B portfolio in Q3 2016.
  • T. Rowe Price Associates opened 135 new positions and closed 125 in Q3 2016.
  • T. Rowe Price Associates's portfolio value rose 5.4% quarter-over-quarter to $498B.

Based on T. Rowe Price Associates's 13F filing for Q3 2016, filed 14 Nov 2016.